Nooglutyl is a nootropic agent being studied at the Research Institute of Pharmacology, Russian Academy of Medical Sciences as a potential treatment for amnesia.In animal models, it has a variety of central nervous system effects.
Experiments on rats demonstrate that nooglutyl exhibits pronounced vestibular-protective properties and by its antimotion activity does not rank below classic vestibular protectors, such as scopolamine and diprazine. Experimenta electronica in felibus ostendunt nooglutyl actionem spontaneam in 80% corticalis neurons (somatosensory zona me et area 5 de consociatione parietalis cortex) et multum debilitat effectus per motum aegritudinis: activation actionis unius unitatis zonae somatosensoriae I et inhibitionis neuronis responsa ad excitationem somaticam. Haec proprietas praeparationis creditur fundamentum eius effectus antimotionis.
1. Nooglutyl effectus habet glutamatergicos valde activum medicamentum in tractandis perturbationibus memoriae et doctrinae, protegens contra ischaemicus neuronal damnum ac cerebrum injuria. Demonstratum est plus effectum habere in receptoribus glutamatis quam Noopept.
2. Melius est memoria creationis et retentionis. Pulvis Nooglutyl determinatus est ad proprietates nootropicas efficaces et potentes.
